Xạ trị thân thể định hướng (SBRT) trong điều trị di căn tuyến thượng thận từ ung thư phổi không tế bào nhỏ

Abrams HL, Spiro R, Goldstein N. Metastases in carcinoma; analysis of 1000 autopsied cases. Cancer 1950;3:74–85. Blomgren H, Lax I, Naslund I et al. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 1995;34:861–70. Chang BK, Timmerman RD. Stereotactic body radiation therapy: a comprehensive review. Am J Clin Oncol 2007;30:637–44. Chawla S, Chen Y, Katz AW et al. Stereotactic body radiotherapy for treatment of adrenal metastases. Int J Radiat Oncol Biol Phys 2009;75:71–5. de Perrot M, Licker M, Robert JH et al. Long-term survival after surgical resections of bronchogenic carcinoma and adrenal metastasis. Ann Thorac Surg 1999;68:1084–5. Duh QY. Resecting isolated adrenal metastasis: why and how? Ann Surg Oncol 2003;10:1138–9. Heniford BT, Arca MJ, Walsh RM et al. Laparoscopic adrenalectomy for cancer. Semin Surg Oncol 1999;16:293–306. Herfarth KK, Debus J, Lohr F, B et al. Extracranial stereotactic radiation therapy: set-up accuracy of patients treated for liver metastases. Int J Radiat Oncol Biol Phys 2000;46:329–35. Herfarth KK, Debus J, Wannenmacher M. Stereotactic radiation therapy of liver metastases: update of the initial phase-I/II trial. Front Radiat Ther Oncol 2004;38:100–5. Katoh N, Onimaru R, Sakuhara Y et al. Real-time tumor-tracking radiotherapy for adrenal tumors. Radiother Oncol 2008;7:418–24. Kebebew E, Siperstein AE, Clark OH et al. Results of laparoscopic adrenalectomy for suspected and unsuspected malignant adrenal neoplasms. Arch Surg 2002;137:948–51. Kim SH, Brennan MF, Russo P et al. The role of surgery in the treatment of clinically isolated adrenal metastasis. Cancer 1998;82:389–94. Lax I, Blomgren H, Naslund I et al. Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol 1994;33:677–83. Lo CY, van Heerden JA, Soreide JA et al. Adrenalectomy for metastatic disease to the adrenal glands. Br J Surg 1996;83:528–31. Lucchi M, Dini P, Ambrogi MC et al. Metachronous adrenal masses in resected non-small cell lung cancer patients: therapeutic implications of laparoscopic adrenalectomy. Eur J Cardiothorac Surg 2005;27:753–6. Luketich JD, Burt ME. Does resection of adrenal metastases from non-small cell lung cancer improve survival? Ann Thorac Surg 1996;62:1614–6. Mercier O, Fadel E, de Perrot M et al. Surgical treatment of solitary adrenal metastasis from non-small cell lung cancer. J Thorac Cardiovasc Surg 2005;130:136–40. Oshiro Y, Aruga T, Tsuboi K et al. Stereotactic body radiotherapy for lung tumors at the pulmonary hilum. Strahlenther Onkol 2010;186:274–9. Porte H, Siat J, Guibert B et al. Resection of adrenal metastases from non-small cell lung cancer: a multicenter study. Ann Thorac Surg 2001;71:981–5. Raviv G, Klein E, Yellin A et al. Surgical treatment of solitary adrenal metastases from lung carcinoma. J Surg Oncol 1990;43:123–4. Sarela AI, Murphy I, Coit DG et al. Metastasis to the adrenal gland: the emerging role of laparoscopic surgery. Ann Surg Oncol 2003;10:1191–6. Short S, Chaturvedi A, Leslie MD. Palliation of symptomatic adrenal gland metastases by radiotherapy. Clin Oncol (R Coll Radiol) 1996;8:387–9. Sobin LH, Wittekind Che, Wiley. UICC: TNM Classification of malignant tumours. 6th edition (2002). New York, UICC 2002. Soffen EM, Solin LJ, Rubenstein JH et al. Palliative radiotherapy for symptomatic adrenal metastases. Cancer 1990;65:1318–20. Therasse P, Arbuck SG, Eisenhauer EA et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205–16. Uematsu M, Sonderegger M, Shioda A et al. Daily positioning accuracy of frameless stereotactic radiation therapy with a fusion of computed tomographyand linear accelerator (focal) unit: evaluation of z-axis with a z-marker. Radiother Oncol 1999;50:337–9. Wang C, Nakayama H, Sugahara S et al. Comparisons of dose-volume histograms for proton-beam versus 3-D conformal x-ray therapy in patients with stage I non-small cell lung cancer. Strahlenther Onkol 2009;185(4):231–4. Wiehle R, Koth HJ, Nanko N et al. On the accuracy of isocenter verification with kV imaging in stereotactic radiosurgery. Strahlenther Onkol 2009; 185:325–30. Wiezorek T, Schwahofer A, Schubert K. The influence of different IMRT techniques on the peripheral dose: a comparison between sMLM-IMRT and helical tomotherapy. Strahlenther Onkol 2009;185:696–702. Wood BJ, Abraham J, Hvizda JL et al. Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases. Cancer 2003;97:554–60. Wulf J, Hadinger U, Oppitz U et al. Stereotactic radiotherapy of extracranial targets: CT-simulation and accuracy of treatment in the stereotactic body frame. Radiother Oncol 2000;57:225–36. Wulf J, Hadinger U, Oppitz U et al. Stereotactic radiotherapy of targets in the lung and liver. Strahlenther Onkol 2001;177:645–55. Zeng ZC, Tang ZY, Fan J et al. Radiation therapy for adrenal gland metastases from hepatocellular carcinoma. Jpn J Clin Oncol 2005;35:61–7. Zimmermann FB, Geinitz H, Schill S et al. Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer. Lung Cancer 2005;48:107–14.